SCHEMBL6173046

SCHEMBL6173046

CC1(Cc2ccncc2C(=O)N2CCCCC2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.37
GAA P10253 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
ALDH1A1 P00352 1/20 0.37
EPHX2 P34913 4/20 0.36
NAMPT P43490 1/20 0.35
TP53 P04637 3/20 0.34
MDM2 Q00987 3/20 0.34
HRH3 Q9Y5N1 2/20 0.34
IDH1 O75874 2/20 0.34
KDM4E B2RXH2 1/20 0.34
AR P10275 1/20 0.33
MAPK7 Q13164 1/20 0.33
LIPE Q05469 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175575 0.93 EPHX2 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6251393 0.92 EPHX2 (0.39) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6175318 0.90 KCNA5 (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6170496 0.87 CYP3A4 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173945 0.87 IGF1R (0.41) AR
SCHEMBL6176355 0.86 CYP3A4 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174456 0.84 MAPT (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174589 0.84 CYP3A4 (0.42) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173349 0.83 ALDH1A1 (0.39) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL3733237 0.82 IGF1R (0.42) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed